Braingaze

braingaze.com ↗ ·Mataró ·Seed

Braingaze is a digital cognitive health company that uses a patented eye-movement biomarker (small involuntary eye movements captured during short gaze-controlled tasks) plus AI to support objective diagnosis and therapy for ADHD, autism and other neurodevelopmental/neurocognitive conditions. Its products are BGaze Clinic, a ~12-minute CE-marked clinician assessment claiming up to 92% accuracy, and BGaze Focus, gaze-controlled therapeutic games; it cites 6,000+ diagnoses supported and 20+ peer-reviewed studies with partners including King's College London and NHS trusts. Founded in 2013 as a University of Barcelona / ICREA spin-off based in Mataró (Barcelona), it raised a €1.5M round in March 2024 and moved its headquarters to the London area while keeping its Spanish operations; it is a small team (2-10 employees).

Founded

2013

Founders

Total funds raised

€2M

SectorsHealthtech, Digital Health, Medtech, Neurotech, AI, Digital Therapeutics Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing

Suggest a correction

Founders

Hans Supèr

Co-founder & CTO

Laszlo Bax

Co-founder & CEO

Global models 5

Akili Interactive

United States · akiliinteractive.com ↗

Makes regulated game-based digital therapeutics for ADHD (EndeavorRx), matching BGaze Focus's therapeutic-games side of the model.

$300M+Comparable

Cognoa

United States · cognoa.com ↗

Sells an AI-based, regulator-cleared diagnostic device (Canvas Dx) that helps clinicians diagnose autism objectively, like BGaze Clinic.

$100MComparable

Linus Health

United States · linus.health ↗

Digital cognitive-assessment platform that uses AI and digital biomarkers from short tasks to give clinicians objective brain-health evaluations.

$80MComparable

EarliTec Diagnostics

United States · earlitec.com ↗

FDA-cleared eye-tracking biomarker device (EarliPoint) sold to clinicians for objective autism diagnosis and assessment, the closest match to Braingaze's eye-movement approach.

$40MComparable

Altoida

United States · altoida.com ↗

AI digital-biomarker platform that captures eye, hand and movement data during short tasks on a device to assess neurocognitive conditions.

$30MComparable

In the same niche 48 others

See all in the Start-ups Map →

Universal Diagnostics

Venture Debt · €25.7M

Biohope

Madrid

No stage disclosed · €15M

iPremom

Valencia

Seed · €15M

+42 more →

Notes: Most funded first

Investors 5

Open as list →

Capital Cell

capitalcell.com

Seed 2016 Spain

RYSE Asset Management

www.ryseam.com ↗

Led Seed 2024 United Kingdom

Across Business Partners

Pre-seed 2014 HQ unknown

Artesian

artesianinvest.com ↗

Seed 2024 Australia

Orbit Startups

orbitstartups.com ↗

Seed 2024 Singapore

Funding rounds 3

Date	Round	Amount	Lead
2024-03-06	Seed (estimated)	€1.5M	RYSE Asset Management +2 more
2016-06-03	Seed	€200K	Lead not disclosed +1 more
2014-07-24	Pre-seed (estimated)	€336K	Lead not disclosed +1 more

News 6

Open as list →

Published	Article
2026-05-27	Mindset-XR Innovation Support Programme company spotlight: Braingaze ↗ Health Innovation Network 2026-05-27
2025-09-26	£3.6 million Innovate UK funding granted to 17 digital mental health tools ↗ HTN Health Tech News 2025-09-26
2025-01-30	Braingaze Launches BGaze Focus: sign up as an exclusive beta tester to gain early access ↗ DigitalHealth.London 2025-01-30
2024-10-07	Cohort Seven of the DigitalHealth.London Launchpad Announced ↗ DigitalHealth.London 2024-10-07
2024-04-16	Tris Pharma Launches Digital Health Business to Develop and Commercialize Digital Products for ADHD ↗ Business Wire 2024-04-16
2024-03-07	Braingaze Raises 1.5 Million to Develop Cognitive Health Solutions ↗ Born2Invest 2024-03-07